Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: Role of suppressant effect in conductivity

European Journal of Pharmacology

Volumn 356, Issue 1, 1998, Pages 31-40

  Iwasa, Atsushi ^a   Okumura, Ken ^a   Tabuchi, Toshifumi ^a   Tsuchiya, Takeshi ^a   Tsunoda, Ryusuke ^a   Matsunaga, Toshiro ^a   Tayama, Shinji ^a   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Conduction velocity; Pilsicainide; Propafenone; Wavelength

Indexed keywords

PILSICAINIDE; PROPAFENONE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDUCTANCE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROPHYSIOLOGY; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VAGUS NERVE STIMULATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC OUTPUT; DOGS; ELECTRIC CONDUCTIVITY; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIA; HEART RATE; HUMANS; LIDOCAINE; MALE; PROPAFENONE; VAGUS NERVE;

EID: 0032575537     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00506-8     Document Type: Article

References (15)

1. Allessie, M.A., Lammers, W.J.E.P., Bonke, F.I.M., Hollen, J., 1985. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes, D.P., Jalife, J. (Eds.), Cardiac Electrophysiology and Arrhythmias. Grune and Stratton, Orlando, FL, pp. 265-275.
2. PSTAF investigators, Atarashi H., Inoue H., Hiejima K., Hayakawa H. Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide (pilsicainide suppression trial on atrial fibrillation). Am. J. Cardiol. 78:1996;694-696.
3. Brugada J., Gursoy S., Brugada P., Atie J., Guiraudon G., Andries E. Cibenzoline transforms random re-entry into ordered re-entry in the atria. Eur. Heart J. 14:1993;267-272.
4. Daoud E.G., Bogun F., Goyal R., Harvey M., Man K.C., Strickberger S.A., Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 94:1996;1600-1606.
5. Hayashi H., Fujiki A., Tani M., Usui M., Inoue H. Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart. J. Cardiovasc. Pharmacol. 31:1998;101-107.
6. Ino K., Atarashi H., Kuruma A., Onodera T., Saitoh H., Hayakawa H. Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class Ic antiarrhythmic agent. J. Cardiovasc. Pharmacol. 31:1998;157-164.
7. Kihara Y., Inoko M., Hatakeyama N., Momose Y., Sasayama S. Mechanism of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. J. Cardiovasc. Pharmacol. 27:1996;42-51.
8. Konings K.T.S., Kirchhof C.J.H.J., Smeets J.R.L.M., Wellens H.J.J., Penn O.C., Allessie M.A. High-density mapping of electrically induced atrial fibrillation in humans. Circulation. 89:1994;1665-1680.
9. Kumagai K., Khrestian C., Waldo A.L. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation. 95:1997;511-521.
10. Rensma P.L., Allessie M.A., Lammers W.J.E.P., Bonke F.I.M., Schalij M.J. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ. Res. 62:1988;395-410.
11. Sasaki R., Inoue D., Ishibashi K., Inoue M., Shirayama T., Yamahara Y., Asayama J., Nakagawa M. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium. J. Cardiovasc. Pharmacol. 25:1995;953-960.
12. Task force of the working group on arrhythmias of the European Society of Cardiology The sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation. 84:1991;1831-1851.
13. Wang Z., Page P., Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ. Res. 71:1992;271-287.
14. Wang J., Bourne G.W., Wang Z., Villemaire C., Talajic M., Nattel S. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation. 88:1993;1030-1044.
15. Wijffels M.C.E.F., Kirchhof C.J.H.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 92:1995;1954-1968.